Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Intangibles (2016 - 2026)

Angiodynamics' Intangibles history spans 16 years, with the latest figure at $65.5 million for Q1 2026.

  • For Q1 2026, Intangibles fell 7.68% year-over-year to $65.5 million; the TTM value through Feb 2026 reached $65.5 million, down 7.68%, while the annual FY2025 figure was $69.1 million, 10.68% down from the prior year.
  • Intangibles reached $65.5 million in Q1 2026 per ANGO's latest filing, down from $66.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $159.1 million in Q1 2022 to a low of $65.5 million in Q1 2026.
  • Average Intangibles over 5 years is $100.3 million, with a median of $81.6 million recorded in 2024.
  • Peak YoY movement for Intangibles: plummeted 39.13% in 2024, then dropped 7.68% in 2026.
  • A 5-year view of Intangibles shows it stood at $141.9 million in 2022, then decreased by 26.81% to $103.9 million in 2023, then dropped by 29.63% to $73.1 million in 2024, then fell by 8.72% to $66.7 million in 2025, then decreased by 1.87% to $65.5 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Intangibles are $65.5 million (Q1 2026), $66.7 million (Q4 2025), and $68.4 million (Q3 2025).